Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R RITTER

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 25, 2001
Autosomal dominant Stargardt-like macular dystrophy: founder effect and reassessment of genetic heterogeneityL A Donoso, A T Frost, E M Stone, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 9, 2010
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell linesAnsgar M Chromik, Adrien Daigeler, Daniel Bulut, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET StudyZhengshi Yang, Sarah J Banks, Aaron R Ritter, et al.
Cancers|November 25, 2023
Factors Associated with Total Laryngectomy Utilization in Patients with cT4a Laryngeal CancerAlex R Ritter, Vedat O Yildiz, Nischal Koirala, et al.
International Clinical Psychopharmacology|September 13, 2001
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's diseaseE Ruether, R Husmann, E Kinzler, et al.
Physical Review Letters|July 23, 2008
Creation of nanohillocks on CaF2 surfaces by single slow highly charged ionsA S El-Said, R Heller, W Meissl, et al.
Biomedicines|July 27, 2022
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in GlioblastomaJennifer K Matsui, Haley K Perlow, Alex R Ritter, et al.
Haematologica|December 7, 2019
LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDAAudrey Belot, Ophélie Gourbeyre, Alexis Fay, et al.
Cancers|September 9, 2022
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology ClinicJennifer K Matsui, Haley K Perlow, Cyril Baiyee, et al.
Journal of Cardiac Failure|May 23, 2007
Hypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchangerKenneth P Roos, Maria C Jordan, Michael C Fishbein, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 25, 2001
Autosomal dominant Stargardt-like macular dystrophy: founder effect and reassessment of genetic heterogeneityL A Donoso, A T Frost, E M Stone, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 9, 2010
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell linesAnsgar M Chromik, Adrien Daigeler, Daniel Bulut, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET StudyZhengshi Yang, Sarah J Banks, Aaron R Ritter, et al.
Cancers|November 25, 2023
Factors Associated with Total Laryngectomy Utilization in Patients with cT4a Laryngeal CancerAlex R Ritter, Vedat O Yildiz, Nischal Koirala, et al.
International Clinical Psychopharmacology|September 13, 2001
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's diseaseE Ruether, R Husmann, E Kinzler, et al.
Physical Review Letters|July 23, 2008
Creation of nanohillocks on CaF2 surfaces by single slow highly charged ionsA S El-Said, R Heller, W Meissl, et al.
Biomedicines|July 27, 2022
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in GlioblastomaJennifer K Matsui, Haley K Perlow, Alex R Ritter, et al.
Haematologica|December 7, 2019
LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDAAudrey Belot, Ophélie Gourbeyre, Alexis Fay, et al.
Cancers|September 9, 2022
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology ClinicJennifer K Matsui, Haley K Perlow, Cyril Baiyee, et al.
Journal of Cardiac Failure|May 23, 2007
Hypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchangerKenneth P Roos, Maria C Jordan, Michael C Fishbein, et al.
Pageof 14